Marinus Pharmaceuticals, Inc.
MRNSDelisted Feb 11, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267813
Marinus Pharmaceuticals, Inc. was delisted on Feb 11, 2025; its insiders filed their last Form 4 on Feb 11, 2025; 53 institutions reported holding it in 13F filings for Q4 2024, worth $15.8M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Marinus Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 90
- −22 vs. Q1 2024
- Shares held
- 43.3M
- −10.5M (−19.6%) vs. Q1 2024
- Total value
- $50.6M
- −$435.9M (−89.6%) vs. Q1 2024
- New holders
- 32
- 24 more added
- Sold out
- 54
- 28 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRNS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 53 | $15.8M |
| Q3 2024 | 75 | $72.9M |
| Q2 2024 | 90 | $50.6M |
| Q1 2024 | 112 | $486.5M |
| Q4 2023 | 105 | $585.2M |
| Q3 2023 | 104 | $411.1M |
| Q2 2023 | 106 | $485.0M |
| Q1 2023 | 86 | $283.9M |
| Q4 2022 | 74 | $165.6M |
| Q3 2022 | 69 | $186.9M |
| Q2 2022 | 73 | $140.6M |
| Q1 2022 | 83 | $280.4M |
| Q4 2021 | 75 | $355.7M |
| Q3 2021 | 82 | $362.0M |
| Q2 2021 | 80 | $563.3M |
| Q1 2021 | 87 | $480.3M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Marinus Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Walleye Capital LLC | 0 | $0 | 0.00% | −185,424−100.0% | Sold out |
| Propel Bio Management, LLC | 0 | $0 | 0.00% | −180,100−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −176,840−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −163,100−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −160,161−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −154,667−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −139,752−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −107,533−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −69,514−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −64,721−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −61,220−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −42,834−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −41,300−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −37,600−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −26,982−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −26,356−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −25,898−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −23,708−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −20,119−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −17,045−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −16,374−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −12,781−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −11,165−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,663−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,163−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −7,823−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −5,574−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −5,521−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −5,506−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −5,249−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,731−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,680−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −317−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −277−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |